Physician

Mujahed Abbas, M.D.

According to 2025 Medicare claims, Mujahed Abbas, M.D. (NPI: 1861500894) practices critical care (intensivists) in the Battle Creek, MI market, with the plurality of this provider's patient population coming from Calhoun, MI. This provider's primary affiliated billing organization is CAPITOL INFECTIOUS DISEASE ASSOCIATES (NPI: 1497205546; TIN: 474487144) and primary practice location at 49015-4188. Abbas is affiliated with the POM ACO (ACO ID: A1297), McLaren High Performance Network, LLC (ACO ID: A3317), Mosaic ACO (ACO ID: A5033), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Abbas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 385 traditional Medicare patients, billed 42,127 HCPCS/CPT codes, and received $487,523 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 658 prescription claims across 143 beneficiaries totaling $149,095 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). 2022 DME data shows 11 claims. Open Payments data shows 20 records totaling $10,240. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $80,386 and ending at $487,523. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $6,532 and ending at $149,095. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	200	622	$80,386
2016	393	1,172	$160,906
2017	536	40,001	$388,425
2018	686	113,927	$1,016,742
2019	690	21,767	$550,025
2020	599	10,087	$400,584
2021	810	4,537	$389,566
2022	480	14,179	$495,240
2023	460	16,995	$665,495
2024	385	42,127	$487,523

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	23	$6,532
2016	31	152	$191,577
2017	76	684	$220,442
2018	91	506	$314,046
2019	73	428	$221,187
2020	143	727	$292,869
2021	163	1,068	$728,861
2022	143	916	$598,234
2023	106	629	$567,099
2024	143	658	$149,095

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	11	$353
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	37	43	$156
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	259	300	$128
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	150	446	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	61	107	$83
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	237	1,430	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	12	360	$49,669
Ertapenem	Ertapenem Sodium	35	229	$16,773
Daptomycin	Daptomycin	42	286	$13,400
Vancomycin Hcl	Vancomycin Hcl	72	598	$7,659
Itraconazole	Itraconazole	23	702	$5,683

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	20	$10,240	Melinta Therapeutics, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mujahed Abbas, M.D.?

Tedicare shows public-source Medicare data for Mujahed Abbas, M.D. (NPI 1861500894), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mujahed Abbas, M.D. have ACO affiliation data?

Mujahed Abbas, M.D. is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297), McLaren High Performance Network, LLC (MSSP, ACO ID A3317), Mosaic ACO (MSSP, ACO ID A5033), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Mujahed Abbas, M.D.?

Mujahed Abbas, M.D. is linked to CAPITOL INFECTIOUS DISEASE ASSOCIATES (billing NPI 1497205546) in the available physician profile data.

Does Mujahed Abbas, M.D. have Open Payments data?

Mujahed Abbas, M.D. has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.